These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1458476)
1. Regulation of smooth muscle alpha-actin promoter in ras-transformed cells: usefulness for setting up reporter gene-based assay system for drug screening. Kumar CC; Bushel P; Mohan-Peterson S; Ramirez F Cancer Res; 1992 Dec; 52(24):6877-84. PubMed ID: 1458476 [TBL] [Abstract][Full Text] [Related]
2. Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells. Bushel P; Kim JH; Chang W; Catino JJ; Ruley HE; Kumar CC Oncogene; 1995 Apr; 10(7):1361-70. PubMed ID: 7731687 [TBL] [Abstract][Full Text] [Related]
3. SCH 51344 inhibits ras transformation by a novel mechanism. Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559 [TBL] [Abstract][Full Text] [Related]
4. Human smooth muscle myosin light chain-2 gene expression is repressed in ras transformed fibroblast cells. Kumar CC; Chang C Cell Growth Differ; 1992 Jan; 3(1):1-10. PubMed ID: 1599878 [TBL] [Abstract][Full Text] [Related]
6. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
7. Smooth muscle alpha-actin promoter activity is induced by serum stimulation of fibroblast cells. Kim JH; Bushel PR; Kumar CC Biochem Biophys Res Commun; 1993 Feb; 190(3):1115-21. PubMed ID: 8439311 [TBL] [Abstract][Full Text] [Related]
8. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145 [TBL] [Abstract][Full Text] [Related]
10. Activation of smooth muscle alpha-actin promoter in ras-transformed cells by treatments with antimitotic agents: correlation with stimulation of SRF:SRE mediated gene transcription. Kumar CC; Kim JH; Bushel P; Armstrong L; Catino JJ J Biochem; 1995 Dec; 118(6):1285-92. PubMed ID: 8720148 [TBL] [Abstract][Full Text] [Related]
11. Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences. March KL; Sandusky G; Fan L Oncogene; 1999 Jun; 18(25):3773-82. PubMed ID: 10391686 [TBL] [Abstract][Full Text] [Related]
12. Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein. Comer KA; Dennis PA; Armstrong L; Catino JJ; Kastan MB; Kumar CC Oncogene; 1998 Mar; 16(10):1299-308. PubMed ID: 9546431 [TBL] [Abstract][Full Text] [Related]
13. [Inhibition of RAS-transformation by SCH51344]. Kumar CC Gan To Kagaku Ryoho; 1997 Sep; 24(11):1503-11. PubMed ID: 9309148 [TBL] [Abstract][Full Text] [Related]
14. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation. Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993 [TBL] [Abstract][Full Text] [Related]
15. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype. Sadhu DN; Lundberg MS; Burghardt RC; Ramos KS J Cell Physiol; 1994 Dec; 161(3):490-500. PubMed ID: 7962130 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Himelstein BP; Lee EJ; Sato H; Seiki M; Muschel RJ Oncogene; 1997 Apr; 14(16):1995-8. PubMed ID: 9150367 [TBL] [Abstract][Full Text] [Related]
17. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Gan Q; Yoshida T; Li J; Owens GK Circ Res; 2007 Oct; 101(9):883-92. PubMed ID: 17823374 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors. Spandidos DA Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595 [TBL] [Abstract][Full Text] [Related]
19. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival. Xin H; Geng Y; Pramanik R; Choubey D J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788 [TBL] [Abstract][Full Text] [Related]
20. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf. Topol LZ; Marx M; Calothy G; Blair DG Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]